Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

48 trials with published results (18%)

Research Maturity

135 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.5%

20 terminated out of 265 trials

Success Rate

87.1%

+0.5% vs benchmark

Late-Stage Pipeline

5%

14 trials in Phase 3/4

Results Transparency

36%

48 of 135 completed with results

Key Signals

48 with results87% success20 terminated

Data Visualizations

Phase Distribution

183Total
Not Applicable (101)
Early P 1 (8)
P 1 (24)
P 2 (36)
P 3 (9)
P 4 (5)

Trial Status

Completed135
Recruiting51
Unknown21
Terminated20
Active Not Recruiting20
Withdrawn11

Trial Success Rate

87.1%

Benchmark: 86.6%

Based on 135 completed trials

Clinical Trials (265)

Showing 20 of 20 trials
NCT07852455Not ApplicableNot Yet Recruiting

E-MOHS Trial of TENS and Vibration During Local Anesthesia

NCT07844681Not ApplicableNot Yet Recruiting

Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision

NCT07843134Phase 4Not Yet Recruiting

Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery

NCT07247123Not ApplicableRecruitingPrimary

Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

NCT07830394Not ApplicableRecruitingPrimary

Mobile Sun Health Intervention EnabLing Daily Protection

NCT04273061Phase 2Recruiting

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

NCT07815574Phase 3Not Yet Recruiting

iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma

NCT07040683Not ApplicableRecruiting

Lower Extremity Graft Study (LEGS): A Multicentre Randomised Controlled Trial of Negative Pressure Wound Therapy Versus Conventional Dressings for Split-thickness Skin Grafts After Lower Leg Skin Tumour Excision

NCT05779423Phase 2Recruiting

Cryoablation+Ipilimumab+Nivolumab in Melanoma

NCT06298734Not ApplicableRecruiting

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

NCT02824289Not ApplicableCompletedPrimary

Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers Phase I

NCT07426484Phase 4Recruiting

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

NCT06439979Not ApplicableRecruiting

Rural Adult and Youth Sun Protection Study

NCT00591500Active Not Recruiting

A Model for Genetic Susceptibility: Melanoma

NCT05715255Not ApplicableActive Not Recruiting

Adaptive Symptom Self-Management Immunotherapy Study

NCT07177638Not ApplicableActive Not RecruitingPrimary

A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.

NCT05634252Phase 3Active Not RecruitingPrimary

Undergraduate Skin Cancer Prevention Trial

NCT07042243Not ApplicableRecruiting

The Florida ASCENT Study

NCT04122456Not ApplicableRecruitingPrimary

DNA Repair Activity in the Skin of Day and Night Shift Workers

NCT06615635Not ApplicableRecruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Scroll to load more

Research Network

Activity Timeline